223 related articles for article (PubMed ID: 33603753)
1. T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells.
Schroeder JH; Meissl K; Hromadová D; Lo JW; Neves JF; Howard JK; Helmby H; Powell N; Strobl B; Lord GM
Front Immunol; 2020; 11():623324. PubMed ID: 33603753
[TBL] [Abstract][Full Text] [Related]
2. Sustained Post-Developmental T-Bet Expression Is Critical for the Maintenance of Type One Innate Lymphoid Cells
Schroeder JH; Roberts LB; Meissl K; Lo JW; Hromadová D; Hayes K; Zabinski T; Read E; Moreira Heliodoro C; Reis R; Howard JK; Grencis RK; Neves JF; Strobl B; Lord GM
Front Immunol; 2021; 12():760198. PubMed ID: 34795671
[TBL] [Abstract][Full Text] [Related]
3. A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.
Klose CS; Kiss EA; Schwierzeck V; Ebert K; Hoyler T; d'Hargues Y; Göppert N; Croxford AL; Waisman A; Tanriver Y; Diefenbach A
Nature; 2013 Feb; 494(7436):261-5. PubMed ID: 23334414
[TBL] [Abstract][Full Text] [Related]
4. T-bet controls intestinal mucosa immune responses via repression of type 2 innate lymphoid cell function.
Garrido-Mesa N; Schroeder JH; Stolarczyk E; Gallagher AL; Lo JW; Bailey C; Campbell L; Sexl V; MacDonald TT; Howard JK; Grencis RK; Powell N; Lord GM
Mucosal Immunol; 2019 Jan; 12(1):51-63. PubMed ID: 30356098
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells.
Powell N; Walker AW; Stolarczyk E; Canavan JB; Gökmen MR; Marks E; Jackson I; Hashim A; Curtis MA; Jenner RG; Howard JK; Parkhill J; MacDonald TT; Lord GM
Immunity; 2012 Oct; 37(4):674-84. PubMed ID: 23063332
[TBL] [Abstract][Full Text] [Related]
6. T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiation.
Stehle C; Rückert T; Fiancette R; Gajdasik DW; Willis C; Ulbricht C; Durek P; Mashreghi MF; Finke D; Hauser AE; Withers DR; Chang HD; Zimmermann J; Romagnani C
Nat Immunol; 2021 Oct; 22(10):1231-1244. PubMed ID: 34556887
[TBL] [Abstract][Full Text] [Related]
7. IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis.
Poholek CH; Dulson SJ; Zajac AJ; Harrington LE
Immunohorizons; 2019 Jun; 3(6):194-202. PubMed ID: 31356165
[TBL] [Abstract][Full Text] [Related]
8. Dichotomous regulation of group 3 innate lymphoid cells by nongastric
Bostick JW; Wang Y; Shen Z; Ge Y; Brown J; Chen ZE; Mohamadzadeh M; Fox JG; Zhou L
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24760-24769. PubMed ID: 31740609
[TBL] [Abstract][Full Text] [Related]
9. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.
Bernink JH; Peters CP; Munneke M; te Velde AA; Meijer SL; Weijer K; Hreggvidsdottir HS; Heinsbroek SE; Legrand N; Buskens CJ; Bemelman WA; Mjösberg JM; Spits H
Nat Immunol; 2013 Mar; 14(3):221-9. PubMed ID: 23334791
[TBL] [Abstract][Full Text] [Related]
10. Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion.
Muraoka WT; Korchagina AA; Xia Q; Shein SA; Jing X; Lai Z; Weldon KS; Wang LJ; Chen Y; Kummer LW; Mohrs M; Vivier E; Koroleva EP; Tumanov AV
Mucosal Immunol; 2021 May; 14(3):703-716. PubMed ID: 33214656
[TBL] [Abstract][Full Text] [Related]
11. Distinct requirements for T-bet in gut innate lymphoid cells.
Sciumé G; Hirahara K; Takahashi H; Laurence A; Villarino AV; Singleton KL; Spencer SP; Wilhelm C; Poholek AC; Vahedi G; Kanno Y; Belkaid Y; O'Shea JJ
J Exp Med; 2012 Dec; 209(13):2331-8. PubMed ID: 23209316
[TBL] [Abstract][Full Text] [Related]
12. NCR
Mikami Y; Scarno G; Zitti B; Shih HY; Kanno Y; Santoni A; O'Shea JJ; Sciumè G
Eur J Immunol; 2018 Jul; 48(7):1174-1180. PubMed ID: 29524223
[TBL] [Abstract][Full Text] [Related]
13. Retinoid orphan receptor gamma t (rorγt) promotes inflammatory eosinophilia but is dispensable for innate immune-mediated colitis.
Torres-Huerta A; Ruley-Haase K; Reed T; Boger-May A; Rubadeux D; Mayer L; Rajashekara AM; Hiller M; Frech M; Roncagli C; Pedersen C; Camacho MC; Hollmer L; English L; Kane G; Boone DL
PLoS One; 2024; 19(3):e0300892. PubMed ID: 38512959
[TBL] [Abstract][Full Text] [Related]
14. Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment.
Zhong C; Cui K; Wilhelm C; Hu G; Mao K; Belkaid Y; Zhao K; Zhu J
Nat Immunol; 2016 Feb; 17(2):169-78. PubMed ID: 26595886
[TBL] [Abstract][Full Text] [Related]
15. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
16. Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.
Withers DR; Hepworth MR; Wang X; Mackley EC; Halford EE; Dutton EE; Marriott CL; Brucklacher-Waldert V; Veldhoen M; Kelsen J; Baldassano RN; Sonnenberg GF
Nat Med; 2016 Mar; 22(3):319-23. PubMed ID: 26878233
[TBL] [Abstract][Full Text] [Related]
17. Innate Lymphoid Cells and Intestinal Inflammatory Disorders.
Zheng M; Zhu J
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163778
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor HIF-1α mediates plasticity of NKp46+ innate lymphoid cells in the gut.
Krzywinska E; Sobecki M; Nagarajan S; Zacharjasz J; Tambuwala MM; Pelletier A; Cummins E; Gotthardt D; Fandrey J; Kerdiles YM; Peyssonnaux C; Taylor CT; Sexl V; Stockmann C
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 35024767
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal transcription factor networks govern tissue-resident ILC3 subset function and identity.
Fiancette R; Finlay CM; Willis C; Bevington SL; Soley J; Ng STH; Baker SM; Andrews S; Hepworth MR; Withers DR
Nat Immunol; 2021 Oct; 22(10):1245-1255. PubMed ID: 34556884
[TBL] [Abstract][Full Text] [Related]
20. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.
Mielke LA; Groom JR; Rankin LC; Seillet C; Masson F; Putoczki T; Belz GT
J Immunol; 2013 Oct; 191(8):4383-91. PubMed ID: 24038093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
